Bright Health Group Stock Profit Margin
| BHGDelisted Stock | USD 12.29 0.39 3.08% |
Bright Health Group fundamentals help investors to digest information that contributes to Bright Health's financial success or failures. It also enables traders to predict the movement of Bright Stock. The fundamental analysis module provides a way to measure Bright Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bright Health stock.
Bright |
Bright Health Group Company Profit Margin Analysis
Bright Health's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Bright Health Profit Margin | (0.58) % |
Most of Bright Health's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bright Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Bright Health Group has a Profit Margin of -0.577%. This is 94.85% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 54.57% lower than that of the firm.
Bright Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bright Health's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bright Health could also be used in its relative valuation, which is a method of valuing Bright Health by comparing valuation metrics of similar companies.Bright Health is currently under evaluation in profit margin category among its peers.
Bright Fundamentals
| Return On Equity | -1.19 | |||
| Return On Asset | -0.0701 | |||
| Profit Margin | (0.58) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 1.25 B | |||
| Shares Outstanding | 7.98 M | |||
| Shares Owned By Insiders | 4.93 % | |||
| Shares Owned By Institutions | 65.02 % | |||
| Number Of Shares Shorted | 104.17 K | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 0.05 X | |||
| Revenue | 2.76 B | |||
| Gross Profit | 205.79 M | |||
| EBITDA | (334.34 M) | |||
| Net Income | (1.59 B) | |||
| Cash And Equivalents | 466.32 M | |||
| Cash Per Share | 3.61 X | |||
| Total Debt | 303.95 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 0.87 X | |||
| Book Value Per Share | (132.46) X | |||
| Cash Flow From Operations | (2.27 B) | |||
| Short Ratio | 1.17 X | |||
| Earnings Per Share | (136.21) X | |||
| Price To Earnings To Growth | (0.01) X | |||
| Target Price | 26.67 | |||
| Number Of Employees | 2.84 K | |||
| Beta | 0.94 | |||
| Market Capitalization | 130.51 M | |||
| Total Asset | 4.67 B | |||
| Retained Earnings | (3.16 B) | |||
| Working Capital | (118.06 M) | |||
| Z Score | -0.37 | |||
| Net Asset | 4.67 B |
About Bright Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bright Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bright Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bright Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Bright Stock
If you are still planning to invest in Bright Health Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bright Health's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |